1 active not recruiting, 1 completed, 1 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Completed 1, Terminated 1 |
Follow Heavy Drinking: new trials by email Literature Review of Heavy Drinking trials Research Report on Heavy Drinking
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Gabapentin to Reduce Alcohol and Improve Viral Load Suppression Gabapentin, Placebo - HIV, Heavy Drinking | Phase 2 | Active not recruiting | Boston Medical Center | 220 | 2023-11-20 | 2026-11-05 |
| Topiramate to Reduce Heavy Drinking in HIV-Positive Heavy Drinkers Topiramate, Medical Management, Placebo - Heavy Drinking, HIV | Phase 2 | Terminated | University of Pennsylvania | 4 | 2013-01-01 | 2016-03-15 |
| Varenicline for Smoking Cessation in Heavy Drinking Smokers Extended Varenicline Pretreatment, Short-term Varenicline Pretreatment - Nicotine Dependence, Smoking | Phase 2 | Completed | Yale University | 30 | 2008-10-01 | 2021-08-13 |
Alcohol Drinking (1) · Alcoholism (1) · Smoking (1) · Smoking Cessation (1) · Tobacco Use Disorder (1)
Behavior (2) · Chemically-Induced Disorders (2) · Mental Disorders (2) · Substance-Related Disorders (2) · Alcohol-Related Disorders (1) · Drinking Behavior (1) · Health Behavior (1)
Gabapentin (1) · Practice Management, Medical (1) · Topiramate (1) · Varenicline (1)
Boston Medical Center (1) · University of Pennsylvania (1) · Yale University (1)
Uganda (1) · United States (1)
Henry R. Kranzler, M.D. (1) · Jeffrey Samet, MD MA MPH (1) · Kara R. Douglas, M.S. (1) · Karsten Lunze, MD MPH DrPH (1) · Stephanie S O'Malley, PhD (1) · Timothy S. Pond, M.P.H. (1)
PMID 21221531, PMID 37142273, PMID 41282191, PMID 42237416
P50AA015632 (1), R01AA030460 (1)